Atomo Diagnostics Ltd has released a press release.
Response to ASX Aware Letter
Filed with ASX · · 11 pages · English
6ix is checking which company filed this.
Earlier from Atomo Diagnostics
- Atomo Completes Capital Raise
- FebriDx FDA CLIA wavier approval unlocks upside for Pascal
- Trading Halt
- Pause in Trading
- Response to ASX Price Query
Later from Atomo Diagnostics
- Share Purchase Plan Results
- Managing Director & CEO Transition
- 2026 Appendix 4E and Annual Report
- Atomo Signs Agreement with Innovation Scientific
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics